Literature DB >> 12711738

The epidemiology of childhood cardiomyopathy in Australia.

Alan W Nugent1, Piers E F Daubeney, Patty Chondros, John B Carlin, Michael Cheung, Lynette C Wilkinson, Andrew M Davis, Stephen G Kahler, C W Chow, James L Wilkinson, Robert G Weintraub.   

Abstract

BACKGROUND: The incidence and age distribution of primary cardiomyopathy in children are not well defined. We undertook a population-based, retrospective cohort study in Australia to document the epidemiology of childhood cardiomyopathy.
METHODS: We analyzed all cases of primary cardiomyopathy in children who presented between 1987 and 1996 and who were younger than 10 years of age. Children were recruited from multiple sources, and cases of cardiomyopathy were classified according to World Health Organization guidelines.
RESULTS: Over the 10-year period, 314 new cases of primary cardiomyopathy were identified, for an annual incidence of 1.24 per 100,000 children younger than 10 years of age (95 percent confidence interval, 1.11 to 1.38). Dilated cardiomyopathy made up 58.6 percent of cases, hypertrophic cardiomyopathy 25.5 percent, restrictive cardiomyopathy 2.5 percent, and left ventricular noncompaction 9.2 percent of cases. The incidence of all types of cardiomyopathy except restrictive declined rapidly after infancy. In 11 cases (3.5 percent), sudden death was the first symptom. There was a male predominance among children with hypertrophic and unclassified cardiomyopathy. Indigenous children had a higher incidence of dilated cardiomyopathy than nonindigenous children (relative risk, 2.67; 95 percent confidence interval, 1.42 to 4.63) and a higher rate of death as the presenting symptom (16.7 percent vs. 2.6 percent, P=0.02). Lymphocytic myocarditis was present in 25 of 62 children with dilated cardiomyopathy (40.3 percent) who underwent cardiac histologic examination within two months after presentation.
CONCLUSIONS: Lymphocytic myocarditis and left ventricular noncompaction are important causes of childhood cardiomyopathy in Australia. The timing and severity of presentation in children with cardiomyopathy are related to the type of cardiomyopathy, as well as to genetic and ethnic factors. Copyright 2003 Massachusetts Medical Society

Entities:  

Mesh:

Year:  2003        PMID: 12711738     DOI: 10.1056/NEJMoa021737

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  164 in total

Review 1.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 2.  The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years.

Authors:  James D Wilkinson; David C Landy; Steven D Colan; Jeffrey A Towbin; Lynn A Sleeper; E John Orav; Gerald F Cox; Charles E Canter; Daphne T Hsu; Steven A Webber; Steven E Lipshultz
Journal:  Heart Fail Clin       Date:  2010-10       Impact factor: 3.179

Review 3.  Isolated ventricular non-compaction of the myocardium in adults.

Authors:  R Jenni; E N Oechslin; B van der Loo
Journal:  Heart       Date:  2006-05-02       Impact factor: 5.994

4.  Electrocardiographic findings at initial diagnosis in children with isolated left ventricular noncompaction.

Authors:  Yakup Ergul; Kemal Nisli; Muhammet Ali Varkal; Naci Oner; Memduh Dursun; Aygun Dindar; Umrah Aydogan; Rukiye Eker Omeroglu
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-04       Impact factor: 1.468

5.  Implications of genetic testing in noncompaction/hypertrabeculation.

Authors:  Joseph T C Shieh
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-07-10       Impact factor: 3.908

6.  Atypical form of left ventricular noncompaction resembling mass appearance in papillary muscles.

Authors:  C E Cagliyan; R E Akilli; A Deniz; O S Deveci; S Demir; M Kanadasi
Journal:  Herz       Date:  2013-08-04       Impact factor: 1.443

7.  Toward Personalized Medicine: Does Genetic Diagnosis of Pediatric Cardiomyopathy Influence Patient Management?

Authors:  Teresa M Lee; Stephanie M Ware
Journal:  Prog Pediatr Cardiol       Date:  2015-07-01

8.  Idiopathic restrictive cardiomyopathy in children.

Authors:  L M Russo; S A Webber
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

9.  Dysregulation of cardiolipin biosynthesis in pediatric heart failure.

Authors:  Kathryn C Chatfield; Genevieve C Sparagna; Carmen C Sucharov; Shelley D Miyamoto; Jonathan E Grudis; Rebecca D Sobus; Jamie Hijmans; Brian L Stauffer
Journal:  J Mol Cell Cardiol       Date:  2014-06-14       Impact factor: 5.000

10.  Tricuspid Atresia with Non-compaction: An Early Experience with Implications for Surgical Palliation.

Authors:  Hoang H Nguyen; Rabia Khan; Norman H Silverman; Gautam K Singh
Journal:  Pediatr Cardiol       Date:  2016-12-10       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.